Ten red flags in the FDA’s risk-benefit analysis of Pfizer’s EUA application to jab American children 5 to 11

By Toby Rogers | October 25, 2021 Where to even begin with the FDA’s preposterous risk-benefit analysis of Pfizer’s mRNA COVID-19 “vaccine” in children ages 5 to 11? Let’s start with my bona fides. I have a year of undergraduate statistics at one of the best liberal arts colleges in America (Swarthmore). I have a year of […]